Cardiff-based EKF Diagnostics Holdings plc is a leading diagnostic instruments, reagents, and ancillary products manufacturer that operates in Europe, the Middle East, the Americas, Asia, Africa, and other international markets. The company's comprehensive product lineup includes the DiaSpect Tm and DiaSpect Hemoglobin T hand-held hemoglobin analyzers, Hemo Control for quantitative and lab quality hemoglobin results, HemataStat II for hematocrit reading, glucose and lactate analyzers such as Biosen C-Line GP+ and C-Line Clinic, Quo-Lab A1c for measuring glycated hemoglobin, Quo-Test A1c for managing diabetes, and STAT-Site M Beta-hydroxybutyrate analyzer. EKF also offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk, QuPID and True20 pregnancy tests, Lactate Scout 4, a lactate analyzer, and clinical chemical analyzers such as Beta-hydroxybutyrate, Glycated Albumin, Glycated Serum Protein, and Nitro-tab Ketone tablets for monitoring ketosis. The company's portfolio includes RaPET Serology immunoassay kits, QuStick Strep A for Strep A infection treatment, Altair 240, a chemistry analyzer, Excel, a semi-automated chemistry analyzer, Micro 12, a micro centrifuge, Hema-Screen Serology, a dependency analyzer for detecting colorectal cancer, Uri-Trak 120 urine analyzer, and COVID-19-related products and services, as well as contract manufacturing solutions and laboratory services offered to third-party businesses. EKF was established in 1990 and continues to expand in global markets.
EKF Diagnostics Holdings plc's ticker is EKF.L
The company's shares trade on the LSE stock exchange
They are based in Cardiff, Wales
There are 201-500 employees working at EKF Diagnostics Holdings plc
It is https://www.ekfdiagnostics.com/
EKF Diagnostics Holdings plc is in the Healthcare sector